Trials / Completed
CompletedNCT01694498
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial Investigating the Efficacy and Safety of Two Different Dose Levels of Desmopressin for the Treatment of Nocturia in Adult Men
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the efficacy and safety of two different dose levels of desmopressin orally disintegrating tablets against placebo for the treatment of nocturia in adult men during 12 weeks treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A: Desmopressin 25 µg | |
| DRUG | B. Desmopressin 50 µg | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-09-27
- Last updated
- 2013-08-23
Locations
35 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01694498. Inclusion in this directory is not an endorsement.